Clin2
NCT04767074Possibly a fitRecruiting

Non-drug therapy to reduce long-term cough in lung scarring

CoughILDPulmonary DiseasePulmonary Fibrosis

Part of Lungs & breathing clinical trials.

This study tests a non-medication cough-control program for people who have lung scarring (interstitial lung disease) and a cough lasting more than 8 weeks. It may help you control coughing better without adding new medicines.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
24 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You have a confirmed diagnosis of interstitial lung disease (ILD) from a doctor
  • Your cough has lasted longer than 8 weeks
  • You do not have moderate or large amounts of phlegm/sputum most days
  • You have not had a recent worsening of your lung condition in the past month
  • You have not had a cold or upper respiratory infection in the past month
  • You can read/speak English and give informed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05086432Recruiting
Test sputum-guided care to reduce cough in lung scarring

This study uses analysis of mucus (sputum) to guide treatment with the goal of reducing long-lasting cough in adults with interstitial lung disease (ILD). You may be asked to provide sputum samples and may receive treatment decisions based on those results.

Hamilton, Ontario
NCT06782893Not yet recruiting
Managing chronic cough in interstitial lung disease

This study tests a program to help people with interstitial lung disease who have had a chronic cough for more than 8 weeks. It is done remotely via video or phone, and aims to find better ways to manage the cough.

Aveiro
NCT05120934Recruiting· Phase 2
Two medicine doses to reduce ILD cough

This Phase 2 study tests whether two different doses of duloxetine and amitriptyline can reduce coughing caused by interstitial lung disease (ILD). If you have had a long-lasting ILD-related cough despite stable ILD treatment, this trial may help find a better way to control your cough.

Rochester, Minnesota
NCT06960759Recruiting· Phase 2
Cough suppression therapy for chronic cough

This study tests a behavior-based therapy to help you gain control over a persistent cough that hasn't responded to other treatments. You will learn techniques to reduce coughing during a 4-week program.

Aurora, Colorado
NCT07488598Recruiting
Behavioral therapy for hard-to-treat chronic cough

This trial tests a behavioral therapy for people whose chronic cough (lasting more than 8 weeks) hasn't improved with usual treatments like asthma or reflux medicine. You may join if your cough is triggered by things like talking, laughing, cold air, or irritants, and you have throat symptoms like irritation or hoarseness.

Asyut
NCT06751069Recruiting
Home exercise and coaching for lung scarring

This study tests a home-based exercise and health coaching program for people with scarring in their lungs (fibrotic ILD). The goal is to see if doing rehab at home, with support from a coach, can help you feel better and breathe easier.

Scottsdale, Arizona

Hear when a new Cough trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.